---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020574"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:16:01.838791+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $82,500 promissory note to accredited investor

## Summary
- Principal amount $82,500; purchase price $75,000; 10% annual interest.
- Maturity date September 15, 2025; proceeds used for general working capital.
- Repayment: 100% of principal if repaid by Aug 18, 2025; 120% if after Aug 18 up to Sept 18, 2025.
- Note issued under private placement exemption Rule 506/Reg D; no equity securities sold.

## SEC filing metadata
- accession: 0001641172-25-020574
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000164117225020574/0001641172-25-020574-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225020574/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020574
- JSON: https://secwatch.observer/filing/0001641172-25-020574.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020574.txt

## Key facts
- Debt Financings
  Propanc Biopharma, Inc. incurred convertible notes of $82,500 with an accredited investor at 10% per annum maturing September 15, 2025.
  - Instrument: convertible notes
  - Principal: $82,500
  - Counterparty: an accredited investor
  - Rate: 10% per annum
  - Maturity: September 15, 2025
  - Event: incurrence
  source text: Effective July 18, 2025, Propanc Biopharma, Inc. (the “Company”) issued a Promissory Note to an accredited investor (the “Investor”) in the aggregate principal amount of 82,500 (the “Note”), for a purchase price of $75,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517681/000164117225020574/0001641172-25-020574-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.